• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.顺铂在麝鼩体内的血浆药代动力学及组织和脑分布
Cancer Chemother Pharmacol. 2015 Jan;75(1):143-52. doi: 10.1007/s00280-014-2623-5. Epub 2014 Nov 15.
2
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.顺铂脂质体包封剂型SPI-77的I期及药代动力学研究
Cancer Chemother Pharmacol. 2002 Mar;49(3):201-10. doi: 10.1007/s002800100371. Epub 2002 Jan 22.
3
Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.对氨基苯甲酸对大鼠顺二氯二氨合铂(II)药代动力学及尿排泄的影响。
Anticancer Res. 1995 Nov-Dec;15(6B):2541-7.
4
Comparative adverse effect profiles of platinum drugs.铂类药物的比较不良反应概况。
Drug Saf. 1995 Oct;13(4):228-44. doi: 10.2165/00002018-199513040-00003.
5
Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.新型顺铂衍生物4-吡啶酸二胺羟基铂经颈内动脉给药后在9L恶性胶质瘤大鼠脑肿瘤中的局部分布及药代动力学:同步脑微透析研究
Biol Pharm Bull. 2000 Dec;23(12):1491-6. doi: 10.1248/bpb.23.1491.
6
Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.新型铂配合物双环铂的I期临床试验:临床及药代动力学结果
Int J Clin Pharmacol Ther. 2013 Feb;51(2):96-105. doi: 10.5414/CP201761.
7
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.顺式二氯(2-甲基吡啶)氨铂(II)(AMD473),一种新型空间位阻铂配合物:小鼠体内活性、毒理学及药代动力学
Clin Cancer Res. 1997 Nov;3(11):2063-74.
8
Pharmacokinetics and tissue distribution of iv injection of polyphase liposome-encapsulated cisplatin (KM-1) in rats.大鼠静脉注射多相脂质体包封顺铂(KM-1)的药代动力学及组织分布
Acta Pharmacol Sin. 2003 Jun;24(6):589-92.
9
Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews.麻醉后呕吐:异氟烷和吗啡对雪貂和鼩鼱的影响。
Physiol Behav. 2012 Jun 25;106(4):562-8. doi: 10.1016/j.physbeh.2012.03.031. Epub 2012 Apr 4.
10
Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.新型铂衍生物(乙醇酸根-0,0')-二胺铂(II)与顺铂和卡铂相比的药代动力学
Cancer Chemother Pharmacol. 1989;23(4):243-6. doi: 10.1007/BF00451649.

引用本文的文献

1
Revolutionizing drug delivery: low-intensity pulsed ultrasound (LIPUS)-driven deep penetration into hypoxic tumor microenvironments of cholangiocarcinoma.药物递送的变革:低强度脉冲超声(LIPUS)驱动深入胆管癌缺氧肿瘤微环境。
Theranostics. 2025 Jan 1;15(1):30-51. doi: 10.7150/thno.99981. eCollection 2025.
2
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?用于胶质母细胞瘤治疗的铂基纳米制剂:铂类药物的复兴?
Nanomaterials (Basel). 2023 May 12;13(10):1619. doi: 10.3390/nano13101619.
3
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?胶质母细胞瘤临床前/临床治疗进展:纳米颗粒能有所帮助吗?
Cancers (Basel). 2022 Oct 10;14(19):4960. doi: 10.3390/cancers14194960.
4
Efficacy and Safety of Human Serum Albumin-Cisplatin Complex in U87MG Xenograft Mouse Models.人血清白蛋白-顺铂复合物在 U87MG 异种移植小鼠模型中的疗效和安全性。
Int J Mol Sci. 2020 Oct 26;21(21):7932. doi: 10.3390/ijms21217932.
5
Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma.颗粒蛋白 A 与顺铂协同抑制人肝癌细胞生长。
Int J Mol Sci. 2018 Oct 7;19(10):3060. doi: 10.3390/ijms19103060.
6
Estimation of body surface area in the musk shrew ( Suncus murinus): a small animal for testing chemotherapy-induced emesis.臭鼩(Suncus murinus)体表面积的估算:一种用于测试化疗引起呕吐的小动物。
Lab Anim. 2017 Oct;51(5):534-537. doi: 10.1177/0023677217695851. Epub 2017 Feb 26.
7
Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.重新利用铂类化疗药物用于胶质母细胞瘤的多模式治疗。
Oncoimmunology. 2016 Aug 19;5(9):e1208876. doi: 10.1080/2162402X.2016.1208876. eCollection 2016.
8
Pharmacokinetics and tissue distribution of novel platinum containing anticancer agent BP-C1 studied in rabbits using sector field inductively coupled plasma mass spectrometry.使用扇形磁场电感耦合等离子体质谱法在兔体内研究新型含铂抗癌剂BP-C1的药代动力学和组织分布。
Drug Test Anal. 2015 Sep;7(9):737-44. doi: 10.1002/dta.1824. Epub 2015 Jun 10.

本文引用的文献

1
Why can't rodents vomit? A comparative behavioral, anatomical, and physiological study.为什么啮齿动物不会呕吐?一项比较行为学、解剖学和生理学的研究。
PLoS One. 2013 Apr 10;8(4):e60537. doi: 10.1371/journal.pone.0060537. Print 2013.
2
Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study.一项评价阿瑞匹坦与 5-HT3 受体拮抗剂和地塞米松联合应用于接受 5 天顺铂联合化疗方案的生殖细胞肿瘤患者的随机、双盲、安慰剂对照、III 期交叉研究:印第安纳肿瘤协作组研究。
J Clin Oncol. 2012 Nov 10;30(32):3998-4003. doi: 10.1200/JCO.2011.39.5558. Epub 2012 Aug 20.
3
Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations.铂类药物的不良事件特征:FDA 不良事件报告系统公共版本(AERS)的数据挖掘和临床观察的重现性。
Int J Med Sci. 2011;8(6):487-91. doi: 10.7150/ijms.8.487. Epub 2011 Aug 16.
4
Behavioral patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews.与化疗引起的呕吐相关的行为模式:麝香鼩鼱恶心的潜在特征。
Front Neurosci. 2011 Jul 14;5:88. doi: 10.3389/fnins.2011.00088. eCollection 2011.
5
Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew.在一种小动物模型(麝鼠)中对癌症化疗引起的呕吐进行计算机化检测和分析。
J Neurosci Methods. 2011 Apr 30;197(2):249-58. doi: 10.1016/j.jneumeth.2011.02.032. Epub 2011 Mar 15.
6
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.MASCC和ESMO预防化疗及放疗引起的恶心和呕吐指南更新:佩鲁贾共识会议结果
Ann Oncol. 2010 May;21 Suppl 5:v232-43. doi: 10.1093/annonc/mdq194.
7
Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.顺铂诱导的呕吐:雪貂模型的系统评价和荟萃分析及 5-HT₃受体拮抗剂的作用。
Cancer Chemother Pharmacol. 2011 Mar;67(3):667-86. doi: 10.1007/s00280-010-1339-4. Epub 2010 May 28.
8
In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion.5-氟尿嘧啶和奥沙利铂在体外循环中的稳定性,以支持热灌注隔离肝灌注。
J Extra Corpor Technol. 2010 Mar;42(1):75-9.
9
The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret.顺铂诱导呕吐的迟发相是由后区介导的,而不是雪貂的腹部内脏神经支配。
Neurosci Lett. 2009 Nov 6;465(1):16-20. doi: 10.1016/j.neulet.2009.08.075. Epub 2009 Sep 3.
10
Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer.腹腔内化疗治疗上皮性卵巢癌的利弊
Anticancer Res. 2009 Jul;29(7):2803-8.

顺铂在麝鼩体内的血浆药代动力学及组织和脑分布

Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.

作者信息

Eiseman Julie L, Beumer Jan H, Rigatti Lora H, Strychor Sandra, Meyers Kelly, Dienel Samuel, Horn Charles C

机构信息

Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.

出版信息

Cancer Chemother Pharmacol. 2015 Jan;75(1):143-52. doi: 10.1007/s00280-014-2623-5. Epub 2014 Nov 15.

DOI:10.1007/s00280-014-2623-5
PMID:25398697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4282608/
Abstract

PURPOSE

Cisplatin induces nausea and emesis, even with antiemetic supportive care. To assess platinum exposure, which could activate nausea and emesis, we quantitated platinum in the brain and various organs, and hindbrain and spinal cord substance P, a key neuropeptide for the neuronal signaling of nausea and emesis.

METHODS

Musk shrews, a model species for nausea and emesis research, were dosed intraperitoneally with 20 mg/kg cisplatin and euthanized at up to 72 h after injection. Concentrations of platinum were quantitated in plasma ultrafiltrate, plasma, lung, kidney, combined forebrain and midbrain, hindbrain, and spinal cord by flameless atomic absorption spectrometry. Hindbrains and spinal cords were analyzed for substance P by immunohistochemistry after injection of 20 or 30 mg/kg.

RESULTS

Plasma ultrafilterable platinum concentrations decreased rapidly till 60 min after dosing and then more slowly by 24 h. The concentrations of total platinum in both the fore- and midbrain and the hindbrain were similar at all time points and were at least 20-fold lower than plasma total platinum concentrations. There were no significant changes in substance P immunoreactivity after cisplatin dosing. Histology revealed damage to the renal cortex by 72 h after injection of cisplatin.

CONCLUSIONS

This is the first study to examine platinum concentrations in musk shrews after administration of cisplatin and delineate substance P immunohistochemical staining in the hindbrain and spinal cord of this species. The platinum concentrations detected in the brain could potentially contribute to the neurological side effects of cisplatin, such as nausea and emesis.

摘要

目的

即使采用止吐支持治疗,顺铂仍会引发恶心和呕吐。为评估可能激活恶心和呕吐的铂暴露情况,我们对大脑及各器官中的铂进行了定量分析,并检测了后脑和脊髓中的P物质,这是一种在恶心和呕吐的神经元信号传导中起关键作用的神经肽。

方法

将麝鼩作为恶心和呕吐研究的模型物种,腹腔注射20mg/kg顺铂,并在注射后长达72小时实施安乐死。通过无火焰原子吸收光谱法对血浆超滤液、血浆、肺、肾、前脑和中脑联合体、后脑及脊髓中的铂浓度进行定量分析。在注射20或30mg/kg后,通过免疫组织化学法对后脑和脊髓进行P物质分析。

结果

给药后60分钟内,血浆中可超滤铂浓度迅速下降,随后至24小时下降更为缓慢。在前脑和中脑以及后脑的所有时间点,总铂浓度相似,且至少比血浆总铂浓度低20倍。顺铂给药后,P物质免疫反应性无显著变化。组织学检查显示,注射顺铂后72小时,肾皮质出现损伤。

结论

这是第一项研究顺铂给药后麝鼩体内铂浓度,并描绘该物种后脑和脊髓中P物质免疫组化染色情况的研究。在大脑中检测到的铂浓度可能会导致顺铂的神经副作用,如恶心和呕吐。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/d8ab74daa97d/nihms642850f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/b94ff368f32c/nihms642850f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/d10115191feb/nihms642850f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/f481b9811599/nihms642850f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/c134c90d8bf7/nihms642850f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/d8ab74daa97d/nihms642850f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/b94ff368f32c/nihms642850f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/d10115191feb/nihms642850f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/f481b9811599/nihms642850f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/c134c90d8bf7/nihms642850f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0455/4282608/d8ab74daa97d/nihms642850f5.jpg